Abstract
Purpose: To report dislocation of dexamethasone implant (Ozurdex®) into the anterior chamber and to discuss intervention options. Design: Interventional case report. Methods: An 89-year-old woman presented after Ozurdex® implant injection for chronic cystoid macular edema secondary to idiopathic intermediate uveitis. The dexamethasone implant dislocated into the anterior chamber. Pharmacologic dilation was administered and the patient was placed in a reclined supine position. Results: Successful repositioning of the implant into the vitreous cavity. Conclusions: Although it is a rare complication, anterior dislocation of a dexamethasone implant may have serious consequences. Early recognition and appropriate management is advisable.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 90-91 |
| Number of pages | 2 |
| Journal | Ocular Immunology and Inflammation |
| Volume | 21 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 2013 |
Keywords
- Anterior chamber dislocation
- Cystoid macular edema
- Dexamethasone intravitreal implant
- Intermediate uveitis
ASJC Scopus subject areas
- Immunology and Allergy
- Ophthalmology
Fingerprint
Dive into the research topics of 'Management of anterior chamber dislocation of dexamethasone implant'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS